Clinical Trials Browser

Phase 2 × Lymphoma, Non-Hodgkin × Immunotherapy, Adoptive × Clear all

NCT06104592 2026-01-08

Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL

Phase 2 Recruiting

Lymphoma, Non-Hodgkin

NCT05260957 2025-12-31

CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma (NHL).

Phase 2 Recruiting

Lymphoma, Non-Hodgkin